Manuel Rodrigues

8.5k total citations
123 papers, 1.4k citations indexed

About

Manuel Rodrigues is a scholar working on Oncology, Ophthalmology and Cancer Research. According to data from OpenAlex, Manuel Rodrigues has authored 123 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 35 papers in Ophthalmology and 32 papers in Cancer Research. Recurrent topics in Manuel Rodrigues's work include Ocular Oncology and Treatments (35 papers), Ovarian cancer diagnosis and treatment (26 papers) and PARP inhibition in cancer therapy (25 papers). Manuel Rodrigues is often cited by papers focused on Ocular Oncology and Treatments (35 papers), Ovarian cancer diagnosis and treatment (26 papers) and PARP inhibition in cancer therapy (25 papers). Manuel Rodrigues collaborates with scholars based in France, Belgium and Italy. Manuel Rodrigues's co-authors include Nathalie Cassoux, Marc‐Henri Stern, Sophie Piperno‐Neumann, Pierre Blanchard, Yohann Loriot, Laurence Albiges‐Sauvin, S. Dewas, Didier Truchot, Vincent Servois and Y. Pointreau and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Manuel Rodrigues

108 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Rodrigues France 20 611 341 337 265 209 123 1.4k
Helen Hickey United Kingdom 19 1.9k 3.2× 317 0.9× 302 0.9× 554 2.1× 846 4.0× 46 3.4k
Festus Njuguna Kenya 20 362 0.6× 274 0.8× 241 0.7× 72 0.3× 111 0.5× 74 1.3k
Weng Ng Australia 20 655 1.1× 34 0.1× 199 0.6× 167 0.6× 181 0.9× 73 1.1k
Danielle Novetsky Friedman United States 23 386 0.6× 153 0.4× 145 0.4× 101 0.4× 268 1.3× 87 1.5k
Kevin S. Scher United States 15 639 1.0× 53 0.2× 119 0.4× 127 0.5× 368 1.8× 43 1.5k
Shripad Banavali India 22 666 1.1× 39 0.1× 304 0.9× 131 0.5× 316 1.5× 170 2.0k
Jenny Wu United States 15 623 1.0× 35 0.1× 198 0.6× 59 0.2× 166 0.8× 38 1.4k
Paul Smith United Kingdom 26 1.2k 1.9× 24 0.1× 534 1.6× 534 2.0× 257 1.2× 65 2.6k
Zarnie Lwin Australia 20 533 0.9× 17 0.0× 193 0.6× 164 0.6× 268 1.3× 99 1.3k
Matthew J. Weiss Canada 22 501 0.8× 38 0.1× 241 0.7× 210 0.8× 237 1.1× 111 1.5k

Countries citing papers authored by Manuel Rodrigues

Since Specialization
Citations

This map shows the geographic impact of Manuel Rodrigues's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Rodrigues with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Rodrigues more than expected).

Fields of papers citing papers by Manuel Rodrigues

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Rodrigues. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Rodrigues. The network helps show where Manuel Rodrigues may publish in the future.

Co-authorship network of co-authors of Manuel Rodrigues

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Rodrigues. A scholar is included among the top collaborators of Manuel Rodrigues based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Rodrigues. Manuel Rodrigues is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piffoux, Max, Alexandra Léary, Philippe Follana, et al.. (2025). Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial. Nature Communications. 16(1). 1821–1821. 1 indexed citations
2.
Zemmour, Christophe, Manuel Rodrigues, Isabelle Ray‐Coquard, et al.. (2025). PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network. The Oncologist. 30(5).
3.
Rodrigues, Manuel, Toulsie Ramtohul, Aurore Rampanou, et al.. (2024). Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp. Nature Communications. 15(1). 8851–8851. 12 indexed citations
4.
Beinse, Guillaume, Valérie Taly, Alexandra Léary, et al.. (2024). 730P Validation of circulating tumor DNA for prognostication and monitoring in metastatic endometrial carcinoma: Ancillary results from the phase II randomized GINECO trial UTOLA. Annals of Oncology. 35. S555–S556. 1 indexed citations
5.
6.
Silveira, André Bortolini, Alexandre Houy, Olivier Ganier, et al.. (2024). Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomes. Nature Communications. 15(1). 9864–9864. 5 indexed citations
7.
Mariani, Pascale, Steven Van Laere, Peter Vermeulen, et al.. (2023). Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases. British Journal of Cancer. 129(5). 772–781. 8 indexed citations
8.
Rodrigues, Manuel, Toulsie Ramtohul, Leanne de Koning, et al.. (2023). PLUME: A single-arm phase II trial evaluating the combination of pembrolizumab and lenvatinib in metastatic uveal melanoma (mUM) patients (pts) previously treated or not with tebentafusp.. Journal of Clinical Oncology. 41(16_suppl). TPS9613–TPS9613. 1 indexed citations
9.
10.
Koning, Leanne de, Vincent Servois, Toulsie Ramtohul, et al.. (2022). Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients. OncoImmunology. 11(1). 2116845–2116845. 11 indexed citations
11.
Labidi‐Galy, Sana Intidhar, Manuel Rodrigues, José Luís Sandoval, et al.. (2022). Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis. Annals of Oncology. 34(2). 152–162. 27 indexed citations
12.
Hélissey, Carole, et al.. (2021). Pourquoi et comment évaluer les sujets âgés atteints de cancer ?. Bulletin du Cancer. 108(5). 513–520. 2 indexed citations
13.
Friedländer, Michael, Sarah J. Lord, Rebecca Asher, et al.. (2021). Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy. European Journal of Cancer. 154. 190–200. 9 indexed citations
14.
Benoit, Louise, Roman Rouzier, Paul Cottu, et al.. (2021). Quality of Life in an e-Cohort of Women Treated by Endocrine Therapy for Early Breast Cancer. Clinical Breast Cancer. 22(3). e352–e361.
15.
Carvalho, Filomena Marino, et al.. (2021). Total cervicothoracic myelitis in a patient with severe COVID-19 pneumonia. European Journal of Neurology. 28. 684–684.
16.
Rodrigues, Manuel, Stéphane Dayot, Alexandre Houy, et al.. (2020). Germline MBD4 Mutations and Predisposition to Uveal Melanoma. JNCI Journal of the National Cancer Institute. 113(1). 80–87. 38 indexed citations
17.
Mariani, Pascale, Sylvain Dureau, Alexia Savignoni, et al.. (2019). Development of a Prognostic Nomogram for Liver Metastasis of Uveal Melanoma Patients Selected by Liver MRI. Cancers. 11(6). 863–863. 20 indexed citations
18.
19.
Loh, Kah Poh, Enrique Soto‐Pérez‐de‐Celis, Tina Hsu, et al.. (2018). What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper. Journal of Oncology Practice. 14(2). 85–94. 111 indexed citations
20.
Rodrigues, Manuel. (2010). Doenças Sexualmente Transmissíveis (DST) na Adolescência. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 19(3). 200–200. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen Hickey Breakdown of academic impact, for papers by Festus Njuguna Breakdown of academic impact, for papers by Weng Ng Breakdown of academic impact, for papers by Danielle Novetsky Friedman Breakdown of academic impact, for papers by Kevin S. Scher Breakdown of academic impact, for papers by Shripad Banavali Breakdown of academic impact, for papers by Jenny Wu Breakdown of academic impact, for papers by Paul Smith Breakdown of academic impact, for papers by Zarnie Lwin Breakdown of academic impact, for papers by Matthew J. Weiss
Rankless by CCL
2026